The SURMOUNT-4 trial found that patients who continued tirzepatide 15 mg lost an additional 5.5% of body weight over 52 weeks, while those switched to placebo regained approximately 14.0% (Aronne et al., JAMA 2024)
GIP activation optimizes sugar processing, aiding better blood sugar regulation and prolonged feelings of fullness
From formulating initial requests to settling insurance follow-ups, Klinic supports each step, ensuring your semaglutide treatment progresses seamlessly
10.1016/S0140-6736(19)33041-7 221 YuanD.ZhaoY.BanksW
Is Semanext Pen Injection safe to use during pregnancy or breastfeeding
Semaglutide significantly improves insulin sensitivity and reduces fasting insulin levels, but reversing insulin resistance is a gradual process involving medication, dietary changes, and consistent physical activity